Clinical Trials Logo

Termination of Pregnancy clinical trials

View clinical trials related to Termination of Pregnancy.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT04910958 Completed - Covid19 Clinical Trials

Impact of COVID-19 Pandemic on Early Spontaneous Abortions and Early Termination of Pregnancy

Start date: January 6, 2021
Phase:
Study type: Observational

To see the impact the COVID-19 pandemic has had on early spontaneous abortions and early termination of pregnancy in the first trimester

NCT ID: NCT04602052 Completed - Clinical trials for Termination of Pregnancy

Comparison of Surgical Versus Medical Termination of Pregnancy Between 13-20 Weeks of Gestation in Ethiopia

Start date: November 1, 2018
Phase: N/A
Study type: Interventional

The purpose of the study is to determine the safety and effectiveness of dilation and evacuation for surgical abortion as compared to medical abortion

NCT ID: NCT03877900 Completed - Neonatal Death Clinical Trials

A Feasibility Study of Virtopsy With Tissue Sampling in Besancon University Hospital

VIRTOPSY+
Start date: February 28, 2019
Phase:
Study type: Observational [Patient Registry]

The aim of this project is to assess the feasibility of a new local post mortem procedure at Besançon University Hospital : Virtopsy+, magnetic resonance (MR) imaging with tissue sampling of the fetus and newborns.

NCT ID: NCT03802149 Completed - Clinical trials for Termination of Pregnancy

Ulipristal Acetate for Cervical Preparation

U-Prep
Start date: April 16, 2019
Phase: Early Phase 1
Study type: Interventional

This is a prospective cohort study exploring a broadened use of ulipristal acetate as a cervical preparation agent for second trimester surgical abortion. Specifically, this pilot study will test the feasibility of using ulipristal as a pharmacologic cervical preparation with adjunct misoprostol prior to surgical abortion.

NCT ID: NCT03393455 Completed - Clinical trials for Termination of Pregnancy

Obstetric & Pediatric Evolution Following Parental Refusal for Early Termination of Pregnancy Despite Fetal Risk

Start date: January 1, 2016
Phase:
Study type: Observational

More and more parents decide to maintain pregnancy which could have been interrupted because of serious fetal pathologies. In this observational study, the investigators examine obstetrical and pediatric evolution of these pregnancies, from 2006 to 2016 in Montpellier University Hospital.

NCT ID: NCT02597699 Completed - Clinical trials for Termination of Pregnancy

Use of Ultiva ® Associated With Xylocaine ® in the Procedures of Feticide

FOETIVA2
Start date: December 18, 2015
Phase: Phase 3
Study type: Interventional

The feticide is a legal and ethical obligation during a termination of pregnancy after 22 weeks' gestation. This method raise concerns about the fetal pain, maternal complications and the fetopathologic analysis. There are few studies on the subject. Investigators want to evaluate a drug in order to facilitate this method technically and emotionally challenging. They want to achieve a quick fetal asystole, a fetal analgesia, a maternal security and a optimal fetopathologic analysis. A drug, remifentanil Ultiva®, seems could meet its properties, it is a powerful morphine. A phase 2 clinical trial has assessed the feasibility, efficacy and safety of Ultiva®. They had not been able to prove bradycardia or lethal effect of Ultiva injected alone but the feasibility and safety were good. Investigators want to set up a randomized clinical trial with 2 arms : Ultiva® and lidocaine versus sufentanil and lidocaine (standard protocol), it is a bicentric study. The primary outcome is the interval between the vascular injection of lidocaine and fetal asystole. The secondary outcomes are the success rate of method, the number of puncture of the umbilical cord, the maternal side effects and the quality of fetopathologic analysis. The previous observational study showed a median interval of 2,3 minutes and a success rate of 55% (lower interval to 2 minutes). From the results they calculate a necessary inclusions to 66 patients. They believe that the bradycardia property of Ultiva® allow a potentiation of the efficacy of lidocaine. If the results are satisfactory, the use of Ultiva® can be generalized to other fetal medicine team.

NCT ID: NCT01811056 Completed - Clinical trials for Termination of Pregnancy

Exploring a Patient-centered Approach to Mifepristone Administration in Medical Abortion

Start date: April 2013
Phase: N/A
Study type: Interventional

This study will test ways to give women more options and flexibility when they are ending their unwanted pregnancies. The investigators will look at uptake and acceptability of using mifepristone outside of the clinic for pregnancy termination.

NCT ID: NCT00994734 Completed - Clinical trials for Termination of Pregnancy

Uptake and Acceptability of Home-use of Mifepristone for Medical Abortion

Start date: May 2009
Phase: N/A
Study type: Interventional

The primary aim of this study is to assess the acceptability of home-use mifepristone for termination of pregnancy among women who choose it and their providers. The investigators' secondary aims are to assess rates of follow-up, adherence, efficacy, complications, lost productivity, and to estimate the minimum proportion of women who choose home-use over clinic use of mifepristone.